Growth Capitalist (https://growthcapitalist.com/author/moriarty/page/105/)
Cytori Therapeutics, Inc. (CYTX) announced that it has secured up to $40,000,000 in an ATM (At the Market) transaction with Cowen and Company. The purchase price is the prevailing market price at the time of the Draw Down Notice. Placement Agent counsel was LeClairRyan and issuer counsel was DLA Piper. An agreement was reached on May 12, 2014. via PlacementTracker.
Celator Pharmaceuticals, Inc (CPXX) announced that it has raised $10,000,000 in a Non-Convertible Debentures transaction. The securities accrue interest at a rate of 9.75%. A series of 158,006 5-Year Warrants exercisable at $2.67 was issued to the investor in this transaction. The investor was Hercules Technology Growth Capital. The transaction closed on May 12, 2014.
AEterna Zentaris Inc. (AEZS) announced that it has secured up to $15,000,000 in an ATM (At the Market) transaction with MLV & Co. LLC. The purchase price is the prevailing market price at the time of the Draw Down Notice. Placement Agent counsel was LeClairRyan, PC and issuer counsels were Norton Rose Fulbright and Ropes & Gray. via PlacementTracker.
RepliCel Life Sciences, Inc. (REPCF) announced that it has raised $2,567,070 in a Units (Common Stock + Warrants) transaction. The common stock was sold at $0.69 per share, an approximate 5% premium to the market price ($0.66) of REPCF at deal announcement. A series of 3,717,167 24-Month Warrants with an exercise price of $0.92 per share (39.52% premium) was issued to the investors in this transaction. Wolverton Securities Limited acted as the exclusive agent on the transaction. The transaction closed on May 09, 2014.
